|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
04.02.26 - 12:24
|
GE HealthCare reports fourth quarter and full year 2025 financial results (Business Wire)
|
|
|
Company exceeds topline and earnings per share expectations; demonstrates operational resilience
Fourth quarter 2025 highlights(1)
Revenue growth of 7.1%, including Organic revenue growth* of 4.8%, driven primarily by the U.S. and Europe, the Middle East and Africa (EMEA)
Net income margin of 10.3% and Adjusted earnings before interest and taxes (EBIT) margin* of 16.7%
Diluted earnings per share (EPS) of $1.29 and Adjusted EPS* of $1.44
Cash flow from operating activities of $1.0 billion and Free cash flow* of $916 million
Full year 2025 highlights(1)
Revenue growth of 4.8%, including Organic revenue growth* of 3.5%
Organic orders growth of 5.2%
Net income margin of 10.1% and Adjusted EBIT margin* of 15.3%
Diluted EPS of $4.55 and Adjusted EPS* of $4.59
Cash flow from operating activities of $2.0 billion and Free cash flow* of $1.5 billion
Company introduces 2026 guidance that reflects growth across all metrics
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the...
|
|
|
|
|
|
|
|
|
|
|
|
|
13.01.26 - 01:48
|
Stocks Rise as Credit Card Shares Slip on Trump Rate Cap Talk | The Close 1/12/2026 (Bloomberg)
|
|
|
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Former Federal Reserve Governor Betsy Duke, GE HealthCare's Peter Arduini, CFRA's Ken Leon, Zoetis' Kristin Peck, Morgan Stanley's Lauren Hochfelder, Blackrock's Jay Jacobs, Cornell University's Eswar Prasad, PGIM's Cathy Marcus, Elanco Animal Health's Jeff Simmons, Pfizer's Albert Bourla. (Source: Bloomberg)...
|
|
|
|
|
07.01.26 - 14:36
|
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors (Business Wire)
|
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Larry Biscotti to its Board of Directors, effective immediately. With this appointment the Sensus Healthcare Board has six Directors, including four independent Directors.
Mr. Biscotti brings more than 25 years of executive leadership experience in the medical device and healthcare technology sectors, with an extensive background in driving commercial strategy, expanding global market share and launching advanced imaging and oncology technologies. He currently serves as President, Imaging for the U.S. and Canada at GE HealthCare, where he is responsible for the company's largest global product and solutions segment. His prior work history includes positions with Elekta, Varian Medical Systems, Toshiba Medical, SMV Nuclear Me...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
